Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days
Confluence Genetics LLC is active in the Biotechnology & Pharmaceuticals technology area and currently has 1 pending office action. This action is situated in 1 distinct art unit, which is typical for specialized pharmaceutical research. The company's current prosecution is highly concentrated in this single matter. The presence of only 1 pending matter indicates a streamlined prosecution phase for the company's current patent filings.
The portfolio is under the review of 1 distinct examiner. KEOGH, MATTHEW R is the busiest examiner, holding 1 busiest examiner pending action. This means that all current feedback from the patent office for Confluence Genetics LLC is coming from this 1 individual. This concentration of 1 pending office action under 1 distinct examiner in the Biotechnology & Pharmaceuticals field allows for a very focused legal strategy.
Because KEOGH, MATTHEW R is the sole examiner, his specific history and preferences will determine the success of the 1 busiest examiner pending action. This lack of examiner diversity reduces the complexity of managing the portfolio's current active matters. Practitioners can focus their resources on addressing the specific concerns of this 1 distinct examiner within the 1 distinct art unit. This targeted approach is essential for resolving the current 1 pending office action efficiently.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBINSON, HOPE A | 1 | 67.7% | +43.1% |
| KEOGH, MATTHEW R | 1 | 78.3% | +14.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18677865 | Soybean Cultivar 3284306 | KEOGH, MATTHEW R | 26d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18677865 | Soybean Cultivar 3284306 | KEOGH, MATTHEW R | 26d overdue |
| 19334536 | COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTS | ROBINSON, HOPE A | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| 1663 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19334536 | COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTS | ROBINSON, HOPE A | 1652 | §112 | Final Rejection | — | Pending | Sep 19, 2025 |
| 18677865 | Soybean Cultivar 3284306 | KEOGH, MATTHEW R | 1663 | §102§112 | Non-Final OA | 26d overdue | Pending | May 29, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial